Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Remote control
Preparation of crosslinked organic porous particlesrelated applications
Catalog and user application for a video provisioning system
Integrated circuit comprising reference voltage generation circuitry and electronic device
Switchable reflective layer for windows and other optical elements
Circular saw
Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disorders
  Randomly Featured Patents
Reprography camera
Watch construction
Connector for fluid supply for a patient infusion
Clay target launcher mount for vehicle
Cable connector
Socket connector having stopping member engaging with latch
Method of producing molded articles
Zymomonas with improved ethanol production in medium containing concentrated sugars and acetate
Film initial-advance apparatus for camera
Methods for drying semiconductor wafer surfaces using a plurality of inlets and outlets held in close proximity to the wafer surfaces